VEA
Virtus ETF Advisers’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,688
| Closed | -$67.9K | – | 358 |
|
|
2024
Q4 | $67.9K | Buy |
2,688
+159
| +6% | +$4.02K | 0.03% | 397 |
|
|
2024
Q3 | $86K | Buy |
2,529
+44
| +2% | +$1.5K | 0.04% | 400 |
|
|
2024
Q2 | $92K | Buy |
2,485
+86
| +4% | +$3.18K | 0.05% | 351 |
|
|
2024
Q1 | $101K | Sell |
2,399
-162
| -6% | -$6.8K | 0.05% | 362 |
|
|
2023
Q4 | $102K | Sell |
2,561
-70
| -3% | -$2.78K | 0.06% | 350 |
|
|
2023
Q3 | $72.4K | Sell |
2,631
-261
| -9% | -$7.18K | 0.04% | 377 |
|
|
2023
Q2 | $98.1K | Buy |
2,892
+379
| +15% | +$12.9K | 0.06% | 394 |
|
|
2023
Q1 | $90.4K | Sell |
2,513
-967
| -28% | -$34.8K | 0.05% | 362 |
|
|
2022
Q4 | $155K | Sell |
3,480
-1,367
| -28% | -$60.9K | 0.08% | 336 |
|
|
2022
Q3 | $136K | Buy |
4,847
+31
| +0.6% | +$870 | 0.05% | 367 |
|
|
2022
Q2 | $130K | Buy |
4,816
+685
| +17% | +$18.5K | 0.05% | 351 |
|
|
2022
Q1 | $141K | Sell |
4,131
-251
| -6% | -$8.57K | 0.06% | 234 |
|
|
2021
Q4 | $169K | Sell |
4,382
-3,483
| -44% | -$134K | 0.06% | 290 |
|
|
2021
Q3 | $425K | Sell |
7,865
-435
| -5% | -$23.5K | 0.19% | 164 |
|
|
2021
Q2 | $278K | Sell |
8,300
-8,164
| -50% | -$273K | 0.11% | 204 |
|
|
2021
Q1 | $339K | Buy |
16,464
+290
| +2% | +$5.97K | 0.14% | 214 |
|
|
2020
Q4 | $283K | Buy |
+16,174
| New | +$283K | 0.12% | 241 |
|
|
2018
Q2 | – | Sell |
-256,431
| Closed | -$597K | – | 264 |
|
|
2018
Q1 | $597K | Buy |
256,431
+137,462
| +116% | +$320K | 0.52% | 106 |
|
|
2017
Q4 | $338K | Sell |
118,969
-20,805
| -15% | -$59.1K | 0.42% | 104 |
|
|
2017
Q3 | $400K | Buy |
139,774
+12,785
| +10% | +$36.6K | 0.05% | 111 |
|
|
2017
Q2 | $314K | Buy |
126,989
+51,752
| +69% | +$128K | 0.05% | 114 |
|
|
2017
Q1 | $272K | Buy |
75,237
+7,213
| +11% | +$26.1K | 0.05% | 149 |
|
|
2016
Q4 | $241K | Buy |
68,024
+8,487
| +14% | +$30.1K | 0.07% | 153 |
|
|
2016
Q3 | $241K | Hold |
59,537
| – | – | 0.12% | 126 |
|
|
2016
Q2 | $261K | Buy |
59,537
+42,290
| +245% | +$185K | 0.19% | 81 |
|
|
2016
Q1 | $65K | Buy |
+17,247
| New | +$65K | 0.09% | 149 |
|